Altogether, the expression of both markers Iba-1 and CD68 in the perivascular microenvironment of the peritumoral niche correlates with a favorable prognosis of patients related to low levels of CMA in PCs, revealing a potential use of these markers for monitoring tumor progression (Figure 3G). This evidence concerns the gene AIF1 and neoplasm.